Immunepath Inc entered the industry of Noncommercial Biotechnical Research in 2010 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 541720, which describes it as a Noncommercial Biotechnical Research. For further clarification, the SIC classifies this business under the code 8733 and described it as a Noncommercial Biotechnical Research. The business provides service to the B2B market.
To acquire more information, please contact John Schloendorn by calling (480) 522-8929 during business hours. You can also write to the business’ Single Location at 3507 Edison Way, Menlo Park, California CA 94025. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Immunepath Inc |
| Representative: | John Schloendorn |
| Place of Business: | 3507 Edison Way, Menlo Park, CA 94025 |
| Contact Number: | (480) 522-8929 |
| Type of Service: | Noncommercial Biotechnical Research |
| SIC Number: | 8733 |
| NAICS Number: | 541720 |
| Locality: | Single Location |
| Market Type: | B2B (Business to Business) |
| Began: | 2010 |
| Income/Year: | $100.000 to $499.999 |
| Laborers: | 1 to 4 |
| Share This Company: |
Immunepath Inc is a company operating from San Mateo, California providing professional Noncommercial Biotechnical Research and relevant B2B variables. It was founded in 2010 and registered with the SIC code 8733 as Noncommercial Biotechnical Research, and with the NAICS code 541720 as Noncommercial Biotechnical Research.
With a current employee count of 1 to 4, Immunepath Inc has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative John Schloendorn at (480) 522-8929 for related queries, or to locate its Single Location using the coordinates 37.476826,-122.195716.
The Single Location can also be found at the street address 3507 Edison Way in Menlo Park, California 94025 and can be engaged online through the company website at , the company Twitter , and Facebook page .